UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 10-K/A
Amendment No. 1
 
(Mark One)

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the fiscal year ended December 31, 2020
 
OR
 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO
 
Commission File Number 001-38238
 
Venus Concept Inc.
(Exact name of Registrant as specified in its Charter)
Delaware
 
06-1681204
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)

235 Yorkland Blvd. Suite 900
Toronto, Ontario M2J 4Y8
(877) 848-8430
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
 
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
 
Trading Symbol
 
Name of each exchange on which registered
Common Stock, $0.0001 par value per share
 
VERO
 
The Nasdaq Global Market
Securities Registered Pursuant to Section 12(g) of the Act: None

Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. YES ☐ NO ☒
 
Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. YES ☐ NO ☒
 
Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES ☒ NO ☐
 
Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files). YES ☒ NO ☐
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
 
Large accelerated filer
 
 
Accelerated filer
 
       
Non-accelerated filer
 
 
Smaller reporting company
 
             
       
Emerging growth company
 

If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐
 
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES NO
 
As of June 30, 2020, (the last business day of the registrant’s most recently completed second quarter), the aggregate market value of Registrant’s common stock, par value $0.0001, held by non-affiliates of the Registrant was $49,700,811 based upon the closing price of $3.49 per share as reported for such date by the Nasdaq Global Market. Shares of the Registrant's common stock held by executive officers and directors of the Registrant and by certain stockholders who owned 10% or more of the outstanding common stock have been excluded because such persons may be deemed to be affiliates of the registrant. This determination of affiliate status is not necessarily a conclusive determination for other purposes.
 
The number of shares of Registrant’s Common Stock outstanding as of March 25, 2021 was 53,971,951.
 
DOCUMENTS TO BE INCORPORATED BY REFERENCE
 
None.



Explanatory Note

This Amendment No. 1 on Form 10-K/A (this “Amendment”) to the Annual Report on Form 10-K of Venus Concept Inc. (the “Company”) for the fiscal year ended December 31, 2020, initially filed with the Securities and Exchange Commission (“SEC”) on March 29, 2021 (the “Original Filing”), is being filed to correct an administrative error in the Original Filing. The Original Filing did not include the correct signature page to the principal executive officer certification dated March 29, 2021 (the “CEO Certification”) filed as Exhibit 31.1 to the Original Filing.

This Amendment is being filed solely to correct the signature page to the CEO Certification. This Amendment includes Item 15 of Part IV of the Original Filing that includes (i) the corrected CEO Certification and (ii) as required by Rule 12b-15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), new certifications by the Company’s principal executive officer and principal financial officer (together, the “New Certifications”) pursuant to Rule 13a-14(a) or 15d-14(a) of the Exchange Act. The Company is not including certifications pursuant to Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. 1350) as no financial statements are being filed with this Amendment.

Except for the foregoing amended information, this Amendment does not amend or update any other information contained in the Original Filing. This Amendment does not reflect events occurring after the filing of the Form 10-K (i.e., occurring after March 29, 2021) or modify or update those disclosures that may be affected by subsequent events. Therefore, this Amendment should be read together with other documents that the Company has filed with the SEC subsequent to the filing of the Original Filing. Information in such reports and documents updates and supersedes certain information contained in the Original Filing.


PART IV

Item 15.
Exhibits, Consolidated Financial Statement Schedules.

(a)
The following documents are filed as part of this report:

3. Exhibits

See the Exhibit Index immediately preceding the signature page of this Annual Report on Form 10-K.

EXHIBIT INDEX

Exhibit
Number
 
Exhibit Description
 
Form
 
Date
 
Number
 
Filed
Herewith
 
Agreement and Plan or Merger and Reorganization, dated March 15, 2019, by and among Restoration Robotics, Inc., Radiant Merger Sub Ltd., and Venus Concept Ltd.
 
8-K
 
3-15-19
 
2.1
   
                      
 
Amendment No. 1, dated August 14, 2019, to the Agreement and Plan of Merger and Reorganization, dated March 15, 2019, by and among Restoration Robotics, Inc., Radiant Merger Sub Ltd., and Venus Concept Ltd.
 
8-K
 
8-20-19
 
2.1
   
                      
 
Second Amendment to the Agreement and Plan of Merger and Reorganization, dated as of October 31, 2019, by and among Restoration Robotics, Inc., Radiant Merger Sub Ltd. and Venus Concept Ltd.
 
8-K
 
10-31-19
 
2.1
   
                      
 
Master Asset Purchase Agreement between Venus Concept Ltd., the Neograft entities, Medicamat and Miriam Merkur, dated January 26, 2018.
 
10-K
 
3-30-20
 
2.4
   
                      
 
Amended and Restated Certificate of Incorporation of Restoration Robotics, Inc.
 
8-K
 
10-17-17
 
3.1
   
                      
 
Certificate of Amendment of Certificate of Incorporation of Restoration Robotics, Inc.
 
8-K
 
11-7-19
 
3.1
   
                      
 
Second Amended and Restated Bylaws of Venus Concept Inc.
 
8-K
 
11-7-19
 
3.2
   
                      
 
Description of Securities.
 
10-K
 
3-29-21
 
4.1
   
                      
 
Form of Common Stock Certificate.
 
S-1/A
 
9-18-17
 
4.2
   
                      
 
Form of 2020 Warrant.
 
10-K
 
3-29-21
 
4.3
   
                      
 
Amendment to 2019 Warrant.
 
8-K
 
3-10-20
 
4.1
   
                      
 
Form of 2019 Warrant.
 
8-K
 
11-7-19
 
4.1
   
                      
 
Form of Madryn Warrant.
 
8-K
 
11-7-19
 
4.2
   
                      
 
Form of Warrant to Purchase Stock, dated November 7, 2019, by and between Venus Concept Inc. and Solar Capital Ltd.
 
8-K
 
11-7-19
 
4.3
   
                      
 
Form of Warrant to Purchase Stock, dated November 2, 2018, by and between Restoration Robotics, Inc. and Solar Capital Ltd.
 
10-K
 
3-20-19
 
4.10
   
                     
 
Form of Warrant to Purchase Stock, dated May 19, 2015, by and between Restoration Robotics, Inc. and Oxford Finance LLC.
 
10-K
 
3-30-20
 
4.9
   
                      
 
Form of Warrant to Purchase Stock, dated November 2, 2018, by and between Restoration Robotics, Inc. and Western Alliance Bank.
 
10-K
 
3-30-20
 
4.10
   
                      
 
Form of Warrant to Purchase Stock, dated November 2, 2018, by and between Restoration Robotics, Inc. and SUNS SPV LLC.
 
10-K
 
3-30-20
 
4.11
   
                      
 
Securities Purchase Agreement, dated as of March 18, 2020, by and between Venus Concept Inc. and the investors listed therein.
 
10-K
 
3-30-20
 
4.12
   
                      
 
Registration Rights Agreement, dated as of March 18, 2020, by and between Venus Concept Inc. and the investors listed therein.
 
10-K
 
3-30-20
 
4.13
   
                      
 
Amended and Restated Investors’ Rights Agreement, dated February 7, 2013, by and among Restoration Robotics, Inc. and the investors listed therein, as amended.
 
S-1
 
9-1-17
 
10.10
   
                      
 
Registration Rights Agreement, dated November 7, 2019, by and between Venus Concept Inc. and the investors listed therein.
 
8-K
 
11-7-19
 
10.2
   
                      
 
Registration Rights Agreement, dated November 7, 2019, by and between Venus Concept Inc. and the investors listed therein.
 
8-K
 
11-7-19
 
10.15
   


Exhibit
Number
 
Exhibit Description
  Form  
Date

 
Number
 
Filed
Herewith
 
Registration Rights Agreement, dated as of June 16, 2020, by and between Venus Concept Inc. and Lincoln Park Capital Fund, LLC.
 
8-K
 
6-16-20
 
10.2
   
                     
 
Second Amended and Restated Loan Agreement, dated March 20, 2020, by and among Venus Concept USA Inc., Venus Concept Canada Corp., Venus Concept Inc. and City National Bank of Florida.
 
8-K
 
3- 24-20
 
10.1
   
                     
 
Second Amended and Restated Guaranty of Payment and Performance, dated as of March 20, 2020, by and between Venus Concept USA Inc., Venus Concept Canada Corp., Venus Concept Inc., and City National Bank of Florida.
 
8-K
 
3- 24-20
 
10.2
   
                     
 
Third Amended and Restated Revolving Promissory Note, dated as of March 20, 2020, by and between Venus Concept USA Inc., Venus Concept Canada Corp., Venus Concept Inc., and City National Bank of Florida.
 
8-K
 
3- 24-20
 
10.3
   
                     
 
Security Agreement, dated as of March 20, 2020, by and between Venus Concept Inc. and City National Bank of Florida.
 
8-K
 
3- 24-20
 
10.4
   
                     
 
License Agreement, dated July 25, 2006 by and between Restoration Robotics, Inc., James A. Harris, M.D. and HSC Development LLC.
 
S-1/A
 
9-22-17
 
10.7
   
                     
 
First Amendment to License Agreement, dated January 5, 2009, by and between Restoration Robotics, Inc., James A. Harris, M.D. and HSC Development LLC.
 
S-1/A
 
9-22-17
 
10.8
   
                     
 
Second Amendment to License Agreement, dated February 23, 2015, by and between Restoration Robotics, Inc., James A. Harris, M.D. and HSC Development LLC.
 
S-1/A
 
9-22-17
 
10.9
   
                     
 
Venus Concept Inc. 2019 Incentive Award Plan.
 
8-K
 
11-7-19
 
10.21
   
                     
 
Form of Stock Option Grant Notice and Stock Option Agreement under the 2019 Incentive Award Plan.
 
10-K
 
3-30-20
 
10.24
   
                     
 
2017 Incentive Award Plan.
 
S-8
 
10-17-17
 
99.7
   
                     
 
Form of Stock Option Grant Notice and Stock Option Agreement under the 2017 Incentive Award Plan.
 
S-1/A
 
9-18-17
 
10.26
   
                     
 
Form of Restricted Stock Award Grant Notice and Restricted Stock Award Agreement under the 2017 Incentive Award Plan.
 
S-1/A
 
9-18-17
 
10.27
   
                     
 
Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the 2017 Incentive Award Plan.
 
S-1/A
 
9-18-17
 
10.28
   
                     
 
2017 Employee Stock Purchase Plan.
 
S-8
 
10-17-17
 
99.11
   
                     
 
Non-Employee Director Compensation Program.
 
S-1/A
 
9-18-17
 
10.35
   
                     
 
2015 Equity Incentive Plan.
 
S-8
 
10-17-17
 
99.4
   
                     
 
Form of Stock Option Grant Notice and Stock Option Agreement under 2015 Equity Incentive Plan.
 
S-1
 
9-1-17
 
10.23
   
                     
 
Form of Stock Purchase Right Grant Notice and Restricted Stock Purchase Agreement under 2015 Equity Incentive Plan.
 
S-1
 
9-1-17
 
10.24
   
                     
 
Venus Concept Ltd. 2010 Israeli Employee Share Option Plan.
 
8-K
 
11-7-19
 
10.20
   
                     
 
Employment Agreement by and between Venus Concept Ltd. and Domenic Serafino, effective January 1, 2016.
 
8-K
 
11-7-19
 
10.16
   
                     
 
Employment Agreement by and between Venus Concept Ltd. and Domenic Della Penna, effective September 5, 2017.
 
8-K
 
11-7-19
 
10.17
   
                     
 
Employment Agreement by and between Venus Concept UK, Ltd. and Søren Maor Sinay, effective August 6, 2019.
 
8-K
 
11-7-19
 
10.18
   
                     
 
Employment Agreement, dated January 24, 2020, by and between Chad A. Zaring and Venus Concept Inc.
 
8-K
 
1-30-20
 
10.1
   
                     
 
Form of Indemnification Agreement between Venus Concept Inc. and each of its directors and executive officers.
 
8-K
 
11-7-19
 
10.19
   
                     
 
Lease Agreement, dated April 16, 2012, by and between Legacy Partners I San Jose, LLC and Restoration Robotics, Inc.
 
S-1
 
9-1-17
 
10.5
   
                     
 
First Amendment to Lease Agreement, dated April 27, 2016, by and between G&I VIII Baytech LP and Restoration Robotics, Inc. and Tenant Estoppel Certificate, dated March 30, 2017, acknowledging Bridge III CA Alviso Tech Park, LLC as successor-in-interest to Landlord thereto.
 
S-1
 
9-1-17
 
10.6
   
                     
 
Second Amendment to Lease Agreement, dated November 7, 2019, by and between Bridge III CA Alviso Tech Park, LLC and Venus Concept Inc.
 
10-K
 
3-30-20
 
10.48
   


Exhibit
Number
 
Exhibit Description
  Form   Date   Number  
Filed
Herewith
 
Lease between 235 Investment Limited, Venus Concept Canada Corp and Venus Concept Ltd, dated March 29, 2019.
 
10-K
 
3-30-20
 
10.49
   
                     
 
Assumption and Amendment Agreement by and between Venus Concept USA Inc., and Jack Fisher ND., dated as of February 8, 2018.
 
10-K
 
3-30-20
 
10.50
   
                     
 
Head of Medical Advisory Board Agreement by and between Venus Concept Ltd. and Dr. Neil Sadick, dated as of June 1, 2016, as amended by 1st Amendment to Head of Medical Advisory Board Agreement, dated as of September 24, 2018.
 
10-K
 
3-30-20
 
10.51
   
                     
 
Quality Agreement, dated November 19, 2017, by and between Venus Concept Ltd. and R.H. Technologies Ltd.
 
10-K
 
3-30-20
 
10.53
   
                     
 
Quality Agreement, dated October 11, 2011, by and between Venus Concept Ltd. and USR Electronnic Systems Ltd. (signed December 3, 2017).
 
10-K
 
3-30-20
 
10.54
   
                     
 
Turn-Key Project Manufacturing Agreement, dated March 23, 2014, by and between Venus Concept Ltd. and USR Electronnic Systems Ltd.
 
10-K
 
3-30-20
 
10.55
   
                     
 
Quality Agreement, dated July 13/17 2018, by and between Venus Concept Ltd. and Electronique du Mazet.
 
10-K
 
3-30-20
 
10.56
   
                     
 
Intellectual Property Rights Assignment, dated February 15, 2018, by and between Venus Concept Ltd. and Electronique du Mazet.
 
10-K
 
3-30-20
 
10-57
   
                     
 
Consent to Transfer Confidentiality and Nonsolicitation Subcontracting Agreement, dated February 1, 2018, by and between Venus Concept Ltd. and Societe de Promotion et d'Equipement Medical Medicamat.
 
10-K
 
3-30-20
 
10-58
   
                     
 
Manufacturing Agreement for Consumables, dated October 26, 2018, by and between NPI Solutions and Restoration Robotics, Inc.
 
10-K
 
3-30-20
 
10-59
   
                     
 
SBA Payroll Protection Program Note dated April 21, 2020, by Venus Concepts Inc. and in favor of City National Bank of Florida.
 
8-K
 
4-30-20
 
10.2
   
                     
 
Purchase Agreement, dated as of June 16, 2020, by and between Venus Concept Inc. and Lincoln Park Capital Fund, LLC
 
8-K
 
6-16-20
 
10.1
   
                     
 
Third Amended and Restated Loan Agreement dated as of December 9, 2020, by and among the Company, Venus Concept USA Inc., Venus Concept Canada Corp. and City National Bank of Florida.
 
8-K/A
 
12-15-20
 
10.1
   
                     
 
Second Amended and Restated Security Agreement dated as of December 9, 2020 by and among the Company, Venus Concept USA Inc. and City National Bank.
 
8-K/A
 
12-15-20
 
10.2
   
                     
 
Fourth Amended and Restated Revolving Promissory Note dated as of December 9, 2020 by Venus Concept USA Inc., Venus Concept Canada Corp. and the Company in favor of City National Bank of Florida.
 
8-K/A
 
12-15-20
 
10.3
   
                     
 
Third Amended and Restated Guaranty of Payment and Performance dated as of December 9, 2020 by Venus Concept Ltd. in favor of City National Bank of Florida.
 
8-K/A
 
12-15-20
 
10.4
   
                     
 
Amendment to General Security Agreement dated as of December 9, 2020 between Venus Concept Canada Corp. and City National Bank of Florida.
 
8-K/A
 
12-15-20
 
10.5
   
                     
 
Loan and Security Agreement dated as of December 8, 2020, by and between Venus Concept USA Inc. and City National Bank.
 
8-K/A
 
12-15-20
 
10.6
   
                     
 
Promissory Note dated December 8, 2020, by Venus Concept USA Inc. in favor of City National Bank.
 
8-K/A
 
12-15-20
 
10.7
   
                     
 
Guaranty of Payment and Performance Agreement dated as of December 8, 2020 by and between the Company and City National Bank.
 
8-K/A
 
12-15-20
 
10.8
   
                     
 
Securities Exchange and Registration Rights Agreement as of December 8, 2020 by and among the Company, Venus Concept USA Inc., Venus Concept Canada Corp., Venus Concept Ltd., Madryn Health Partners, LP and the Investors.
 
8-K/A
 
12-15-20
 
10.9
   
                     
 
Secured Subordinated Convertible Note dated as of December 9, 2020 by the Company in favor of Madryn Health Partners, LP.
 
8-K/A
 
12-15-20
 
10.10
   
                     
 
Secured Subordinated Convertible Note dated as of December 9, 2020 by the Company in favor of and Madryn Health Partners (Cayman Master), LP.
 
8-K/A
 
12-15-20
 
10.11
   
                     
 
Guaranty and Security Agreement dated as of December 9, 2020 by and among the Company, Venus Concept USA, Venus Concept Canada Corp., Venus Concept Ltd. and Madryn Health Partners, LP.
 
8-K/A
 
12-15-20
 
10.12
   


Exhibit
Number
  Exhibit Description   Form   Date   Number  
Filed
Herewith
 
Subordination of Debt Agreement dated as of December 9, 2020 by and among Madryn Health Partners, LP, Madryn Health Partners (Cayman Master), LP, City National Bank and Venus Concept Inc.
 
8-K/A
 
12-15-20
 
10.13
   
                     
 
Subordination of Debt Agreement dated as of December 9, 2020 by and among Madryn Health Partners, LP, Madryn Health Partners (Cayman Master), LP, City National Bank and Venus Concept Canada Corp.
 
8-K/A
 
12-15-20
 
10.14
   
                     
 
Subordination of Debt Agreement dated as of December 9, 2020 by and among Madryn Health Partners, LP, Madryn Health Partners (Cayman Master), LP, City National Bank and Venus Concept USA Inc.
 
8-K/A
 
12-15-20
 
10.15
   
                     
 
Code of Business Conduct and Ethics.
 
8-K
 
11-7-19
 
14.1
   
                     
 
List of Subsidiaries.
 
10-K
 
3-29-21
 
21.1
   
                     
 
Consent of MNP LLP, independent registered public accounting firm.
 
10-K
 
3-29-21
       
                     
 
Power of Attorney. Reference is made to the signature page of this Annual Report on Form 10-K.
 
10-K
 
3-29-21
 
24.1
   
                     
 
Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes- Oxley Act of 2002.
             
X
                     
 
Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes- Oxley Act of 2002.
             
X
                     
 
Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes- Oxley Act of 2002.
             
X
                     
32.1*
 
Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
10-K
 
3-29-21
 
32.1
   
                     
32.2*
 
Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
10-K
 
3-29-21
 
32.2
   
                     
101.INS
 
XBRL Instance Document
 
10-K
 
3-29-21
 
101.INS
   
                     
101.SCH
 
XBRL Taxonomy Extension Schema Document
 
10-K
 
3-29-21
 
101.SCH
   
                     
101.CAL
 
XBRL Taxonomy Extension Calculation Linkbase Document
 
10-K
 
3-29-21
 
101.CAL
   
                     
101.DEF
 
XBRL Taxonomy Extension Definition Linkbase Document
 
10-K
 
3-29-21
 
101.DEF
   
                     
101.LAB
 
XBRL Taxonomy Extension Label Linkbase Document
 
10-K
 
3-29-21
 
101.LAB
   
                     
101.PRE
 
XBRL Taxonomy Extension Presentation Linkbase Document
 
10-K
 
3-29-21
 
101.PRE
   


#
Indicates management contract or compensatory plan.
 

Certain confidential portions of this exhibit were omitted by means of marking such portions with asterisks because the identified confidential portions (i) are not material and (ii) would be competitively harmful if publicly disclosed.
 

*
The certifications attached as Exhibit 32.1 and Exhibit 32.2 that accompany this Annual Report on Form 10-K are not deemed filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of Venus Concept Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Annual Report on Form 10-K, irrespective of any general incorporation language contained in such filing.


SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 
Venus Concept Inc.
     
Date: December 22, 2021
By:
/s/ Domenic Serafino
   
Domenic Serafino
   
Chief Executive Officer and Director




Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
 
I, Domenic Serafino, certify that:
 
I have reviewed this annual report on Form 10-K of Venus Concept Inc.;
 
1.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
2.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
3.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13(a)-15(f) and 15d-15(f)) for the registrant and have:
 
  (a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
  (b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 

(c)
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 

(d)
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's fourth fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
 
4.
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
 

(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
 

(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


[SIGNATURE PAGE FOLLOWS]

Date: March 29, 2021
By:
/s/ Domenic Serafino
   
Name: Domenic Serafino
   
Chief Executive Officer
   
(Principal Executive Officer)




Exhibit 31.2

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
 
I, Domenic Serafino, certify that:
 
I have reviewed this annual report on Form 10-K/A of Venus Concept Inc.;
 
1.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
2.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
3.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13(a)-15(f) and 15d-15(f)) for the registrant and have:
 
  (a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
  (b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
  (c)
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
  (d)
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's fourth fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
 
4.
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
 
  (a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
 
  (b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


[SIGNATURE PAGE FOLLOWS]

Date: December 22, 2021
By:
/s/ Domenic Serafino
   
Name: Domenic Serafino
   
Chief Executive Officer
   
(Principal Executive Officer)




Exhibit 31.3

CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
 
I, Domenic Della Penna, certify that:
 
I have reviewed this annual report on Form 10-K/A of Venus Concept Inc.;
 
1.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
2.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
3.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13(a)-15(f) and 15d-15(f)) for the registrant and have:
 

(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 

(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 

(c)
Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 

(d)
Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's fourth fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
 
4.
The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
 

(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
 

(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


[SIGNATURE PAGE FOLLOWS]

Date: December 22, 2021
By:
/s/ Domenic Della Penna
   
Name: Domenic Della Penna
   
Chief Financial Officer
   
(Principal Financial Officer)